|
|
|
| Study on optimizing potential of development environment of Yunnan TCM industry |
| ZHANG Xiaoyan1 YANG Yang2 ZHANG Difan3 GAO Jie3 CAI Yunhai1 MAO Xiangming4 |
1.President′s Duty Office, Yunnan University of TCM, Yunnan Province, Kunming 650500, China;
2.Faculty of Basic Medicine, Yunnan University of TCM, Yunnan Province, Kunming 650500, China;
3.Higher Education Research & Evaluation Center, Yunnan University of TCM, Yunnan Province, Kunming 650500, China;
4.Party Committee Office, Yunnan University of TCM, Yunnan Province, Kunming 650500, China |
|
|
|
Abstract Any industry develops in the surrounding outer environment. In recent years, traditional Chinese medicine (TCM) industry of Yunnan Province develops rapidly, and it has already become the largest and most influential area in the biomedical industry of whole province. However, its development environment is restricted by such factors as weak industrial linkage, insufficient talent support, weak innovation ability and limited comprehensive competitiveness of enterprises. With regards to the high attention of Yunnan provincial Party Committee and provincial government, good industrial foundation, rich resources of Chinese medicinal materials, rich national medical culture, and accelerating standardization construction, Yunnan TCM industry has great potential for optimization of development environment. Thus, it is suggested to strengthen top-level design and guidance, increase talent cultivation and guidance, enhance innovation drive, and let TCM enterprises become large and special, so as to effectively optimize the development environment of Yunnan′s TCM industry, and to promote industrial transformation and upgrading.
|
|
|
|
|
|
[1] 段晓瑞，王玮，赵树发.云南生物医药产业发展势头强劲 中药产值14年增长300亿[EB/OL].（2015-04-17）[2017-08-15]. http://cnews.chinadaily.com.cn/2015-04/17/content_20455142.htm.
[2] 云南省旅发委宣传中心.“魅力彩云南·特色云系列”之百年云药篇[EB/OL].（2015-04-16）[2016-09-13]. http://www.ynta.gov.cn/Item/20734.aspx.
[3] 林玉孝.巩固中药民族药主导地位大力推进云南生物医药产业发展[EB/OL].（2015-04-16）[2017-08-15]. http://special.yunnan.cn/feature12/html/2015-04/16/content_369 4376.htm.
[4] 李映青.云南省出台《指导意见》促中药（民族药）产业发展[EB/OL].（2015-04-16）[2018-07-19]. http://cnews.chinadaily.com.cn/2015-04/16/content_20451759.htm.
[5] 王坤硕.云南白药入选2017年中国品牌100强[EB/OL].（2017-05-26）[2017-11-23]. http://www.xinhuanet.com/health/2017-05/26/c_1121043683.htm.
[6] 纳敏，王华祥.云南医药产业发展存在的问题及对策研究[J].经济问题探索，2009（3）：85-88.
[7] 杨抒燕.云南生物医药和大健康产业发展强劲[N].云南日报，2018-06-12（E03）.
[8] 王利平.健康云南还需多补钙[J].云岭先锋，2016（8）：18-19.
[9] 李树洁.提升云南医药产业科技能力对策研究[J].中国科技产业，2004（6）：32-35.
[10] 刘斯，于克信.云南中药产业竞争力提升策略研究[J].现代商贸工业，2010，22（7）：13-15.
[11] 陈静.云南中医药将借科技破除粗放型产业发展现状[EB/OL].（2016-02-20 ）[2017-08-15]. http://www.chinanews.com/df/2016/02-20/7765760.shtml.
[12] 彭锡.2016年云南中药材产业种植面积达665万亩 居全国第一[EB/OL].（2017-06-05）[2017-08-15]. http://yn.yunnan.cn/html/2017-06/05/content_4845007.htm.
[13] 念新洪.2017云南中药材种植面积达747万亩 3个品种纳入流通追溯体系[EB/OL].（2017-06-11）[2018-06-13]. http://www.yn.xinhuanet.com/original/2018-06/11/c_137246513.htm.
[14] 郑进.云南民族医药发展概述[J].云南中医学院学报，2009，29（8）：4-7.
[15] 王海东.中医药国际化之路[M].武汉：湖北科学技术出版社，2016.
[16] 李美娇.“大健康”蓄力发展正当时[J]云岭先锋，2016（8）：12-13.
[17] 陈怡希.《中医药——三七药材》国际标准颁布实施[N].云南日报，2017-12-12（E01）.
[18] 包青.云南中药产业发展的比较优势及战略调整[J].学术探索，2002（1）：143-145.
[19] 张晓燕，邱勇，章涤凡，等.“一带一路”战略下云药国际化发展的政策法规壁垒与对策分析[J].中国医药导报，2017，14（6）：176-180.
[20] 辛文锋，张文生，王维生，等.云南省大中药产业发展制约因素与对策浅析[J].中国中药杂志，2012，37（10）：1509-1512. |
|
|
|
